Oscar Teijido Hermida obtained his PhD in Biology at the University of Barcelona (2007) in the fields of Neurobiology and Biochemistry. After eight years of postdoctoral experience at New York University (NYU) and the National Institutes of Health (NIH), he returned to Spain to lead the Medical Epigenetics Laboratory at the EuroEspes Biomedical Research Center for three years. He has currently been participating in a research line aimed at implementing whole human genome analysis (WGS) technology in the public health network as a clinical, research, and development tool associated with precision medicine. One of these projects, “PharmaNagen”, was awarded by the International Consortium for Personalized Medicine (ICPerMed), achieving the second prize for 'Best International Practice in Personalized Medicine' for the efforts on the implementation of genomic medicine in healthcare practice. He is currently working as an assistant professor at the Health Sciences Department of the Public University of Navarra. His research activity results in the publication of 35 articles and 5 book chapters, accumulating more than 1600 citations in the fields of Molecular Genetics, Neurobiology, Genomic Medicine, and Pharmacogenetics. Óscar Teijido is currently a board member of the Spanish Society of Pharmacogenetics and Pharmacogenomics (SEFF), where he also participates in the Methodology and Analytic Implementation Working Group.
'Best International Practice in Personalized Medicine'
International Consortium for Personalized Medicine (ICPerMed)
the second prize for 'Best International Practice in Personalized Medicine' for the efforts on the implementation of genomic medicine in healthcare practice.